Stool tests may detect coronavirus more effectively than respiratory tests in infants and children, according to researchers at the Chinese University of Hong Kong (CUHK) who said in a report ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.

Mayo Clinic researchers conducted a study comparing the efficacy of multitarget stool DNA tests to fecal immunochemical testing for colorectal cancer screening in Alaska Native people. Here are six ...

Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

March marks the beginning of Colorectal Cancer Awareness Month. At-home stool tests can be an easier way to screen for colorectal cancer than a dreaded colonoscopy. As the rates of the cancer continue ...

The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of Annals of Internal Medicine.

Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The "GI Stool Testing Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The increasing burden ...

New York, United States , Aug. 21, 2024 (GLOBE NEWSWIRE) -- The Global GI Stool Testing Market Size is Expected to Grow from USD 580.0 Million in 2023 to USD 1195 Million by 2033, at a CAGR of 7.50% ...